# A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

> **NCT00403286** · PHASE2 · COMPLETED · sponsor: **Dey** · enrollment: 457 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Fluticasone Propionate/Formoterol Fumarate
- **DRUG:** Fluticasone Propionate/Formoterol Fumarate
- **DRUG:** Fluticasone Propionate/Formoterol Fumarate
- **DRUG:** Fluticasone Propionate/Formoterol Fumarate
- **DRUG:** Fluticasone Propionate
- **DRUG:** Formoterol Fumarate
- **DRUG:** Fluticasone Propionate/Salmeterol Xinafoate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00403286
- **Lead sponsor:** Dey
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 457 (ACTUAL)
- **Last updated:** 2009-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00403286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00403286, "A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00403286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*